DTL
ZYNE

Dynamic Technology Lab’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Dynamic Technology Lab’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,021
Closed -$63K – 1441
2020
Q3 		$63K Buy
+19,021
New +$69.9K 0.01% 915
2020
Q1 		– Sell
-42,782
Closed -$258K – 1453
2019
Q4 		$258K Buy
+42,782
New +$293K 0.04% 739
2017
Q2 		– Sell
-20,407
Closed -$410K – 1397
2017
Q1 		$410K Buy
+20,407
New +$406K 0.1% 396

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Dynamic Technology Lab's ZYNE Position: Q4 2020 in Review

Dynamic Technology Lab sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2020, closing a stake of 19,021 shares — an estimated $63K sold.

Dynamic Technology Lab first reported a position in ZYNE in Q1 2017 and held it in 3 quarters. The position peaked at $410K in Q1 2017. 58 funds tracked by Wall St. Rank hold ZYNE as of Q4 2020.

  • Dynamic Technology Lab reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2020 after selling out during the quarter.
  • Dynamic Technology Lab sold 19,021 Zynerba Pharmaceuticals, Inc shares in Q4 2020, an estimated $63K.
  • Dynamic Technology Lab first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2017 and held it in 3 quarters.
  • Dynamic Technology Lab's Zynerba Pharmaceuticals, Inc position peaked at $410K in Q1 2017.
  • 58 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2020.

Based on Dynamic Technology Lab's 13F filing for Q4 2020, filed 11 Feb 2021.